Status:
UNKNOWN
Comparison of Novo Rapid 30 Mix Injection FlexPen® and Humalog 25 Mix Injection KwikPen® in Type 2 Diabetic Patients
Lead Sponsor:
Nagaoka Red Cross Hospital
Conditions:
Diabetes Complications
Diabetes Mellitus, Type 2
Eligibility:
All Genders
20-80 years
Phase:
NA
Brief Summary
The purpose of this study is to investigate patient's usability, preference and blood glucose control for the new prefilled disposable insulin lispro mixture (Humalog Mix 25 injection KwikPen®). For t...
Detailed Description
* Concomitant drugs The treatment with other insulin preparation is prohibited during the study period. As to the drugs except insulin that have been used for the treatment of diabetes and its complic...
Eligibility Criteria
Inclusion
- Type 2 diabetes mellitus patients
- Patients who have used Humalog Mix 25 injection KwikPen® or Novo Rapid 30 Mix injection FlexPen® for 3 months or more.
- Outpatients regularly visiting hospital
- Patients 20 years old or older but under 80 years old (gender is disregarded)
Exclusion
- Patients with a serious complication in the heart, liver or kidney
- Pregnant or possibly pregnant patients, or lactating patients
- Patients complicated with a malignant tumor at present.
- Patients allergic to insulin analog preparations.
- Patients taking an illegal drug.
- Patients participating in other clinical study.
- Other than the above, patients judged inappropriate as the subjects of this study by the investigator
Key Trial Info
Start Date :
January 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 1 2009
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00806975
Start Date
January 1 2009
End Date
June 1 2009
Last Update
December 11 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nagaoka Red Cross Hospital
2-291 Nagaoka, Niigata, Japan, 940-2085